LMI has been selected to support the U.S. Army’s Combat Capabilities Development Command Chemical Biological Center via a 10-year, potential $869 million Scientific, Technical, Engineering and Program Support Services multiple-award task order.
Under the contract, LMI will continue helping prepare the U.S. Army to detect and respond to chemical, biological, radiological and nuclear threats. The company will develop and provide technical expertise under STEPSS, and provide acquisition and engineering support.
“We are proud to expand our partnership with the U.S. Army to expand our robust analytics and digital transformation support,” said LMI president and CEO Doug Wagoner. “With improved data-centric decision-making capabilities, our armed forces will have increased capability to quickly identify, respond to, and prevent CBRN threats to keep our nation safe.”
DEVCOM CBC activities span the lifecycle from chemical and biological defense research to product development and technical support services for CBC across a spectrum of requirements, including research, development, test and evaluation; engineering; acquisition support; product development; and chemical and biological demilitarization operations.
LMI’s support for the STEPSS program will build on nearly six decades of multidisciplinary past performance, from cost savings and security for supply chains to artificial intelligence and machine learning.